Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 7665 - 7672 of 12086 results

Unlocking Private Sector Capital for Small and Growing Businesses Around the World
November 14, 2016| News

Recent Developments around Pharmaceutical Drug Spending in Massachusetts
November 14, 2016| Alert| Viewpoint

USCIS Revises Form I-9
November 14, 2016| Alert| Viewpoint

What the Election Means for Health Care - Insight from ML Strategies
November 11, 2016| Blog| Viewpoint

An Ombudsman in Shining Armor: Spotlight on the USPTO Patents Ombudsman Program
November 11, 2016| Blog| Viewpoint

Big Law Helps Veterans Transition to Civilian Life
November 11, 2016| News

Flash: What the Election Means for Health Care
November 11, 2016| Alert| Viewpoint

CPSC in a Post-Election Government: Restraint and Moderation Are Required by All Sides
November 11, 2016| Blog| Viewpoint
News & Press Releases
Mintz advised the creators of Morbid, one of the top-charting true crime podcasts, in a multi-year agreement to move to SiriusXM from Wondery. The deal gives SiriusXM exclusive advertising rights for the audio and video formats of the podcast.
Mintz Advises CVC DIF in Acquisition of SBA Communications’ Canadian Tower Infrastructure Platform
August 06, 2025
Mintz advised CVC DIF, the dedicated infrastructure investment strategy of global private markets manager CVC, in its agreement to acquire SBA Communications’ Canadian wireless tower business, one of Canada’s leading independent owners and operators of wireless communications towers. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions.
Mintz advised the underwriters in connection with a $69 million public offering by Larimar Therapeutics, Inc. of 21,562,500 shares of its common stock at a price to the public of $3.20 per share. The gross proceeds to Larimar from the offering were $69 million before deducting underwriting discounts and commissions and other offering expenses.
Events
Podcasts

Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|

Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
